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GENERAL INTRODUCTION 
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   Lymphoid malignancies are defined as clonal expansion of lymphoid cells originated from 
one transformed cell. They are one of the most common neoplastic diseases in dogs. Lymphoid 
neoplasms are generally diagnosed based on histopathological or cytological examination with 
or without immunostaining of cellular antigens (Fournel-Fleury et al., 1997; Valli et al., 2011). 
However, their pathological diagnosis is sometimes difficult when specimens include only small 
number of tumor cells or neoplastic population comprising small lymphoid cells, which is 
difficult to distinguish from reactive ones. Therefore, more objective diagnostic strategy has 
been required for the accurate diagnosis of lymphoid neoplasms.  
   For attaining more accurate diagnosis of lymphoid malignancies, assessment of the 
rearrangements of lymphocyte antigen receptor genes, immunoglobulin (Ig) and T cell receptor 
(TCR) genes, has been commonly performed as a useful adjunctive method. Antigen receptor 
genes consist of randomly combined variable (V), diverse (D), and joining (J) gene segments in 
early lymphoid development. During the process of recombination, several nucleotides are 
randomly inserted or deleted in junctional regions between each gene segments, producing 
diverse length and sequence among each lymphoid cells, which is called complementary 
determining region 3 (CDR3) (Jung et al., 2006). In normal tissues, since various lymphocytes 
heterogeneously exist, polyclonal patterns of antigen receptor gene rearrangements are found. 
On the other hand, since lymphoid malignancies are composed of a clonally expanded cell 
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population, all of the neoplastic cells in each tumor have a uniform antigen receptor gene 
rearrangement. 
   Clonality of lymphocytes are commonly analyzed by amplifying CDR3 using polymerase 
chain reaction (PCR) with primers annealing to V and J segments, which is generally called 
PCR for antigen receptor gene rearrangements (PARR). PARR is followed by separation of the 
PCR products according to its nucleotide length using polyacryl amide gel electrophoresis 
(PAGE). This PAGE method has been widely used in dogs (Burnett et al., 2003; Tamura et al., 
2006; Valli et al., 2006; Yagihara et al., 2007). Several studies have been conducted to improve 
its accuracy by designing multiple primer sets. In addition, heteroduplex analysis has been 
generally employed to avoid false positive results. However, it is difficult to discriminate 
fragments with differences less than 5 bp when using PAGE. 
   To avoid this pitfall, GeneScan analysis has been introduced in human medicine (van 
Dongen et al., 2003). GeneScan technique involves separation of fragments through capillary 
electrophoresis together with detection of fluorescent-labeled primers. There are several 
advantages in GeneScan compared with PAGE. First, higher resolution ability, which can 
separate fragments by only 1 nucleotide, can avoid false positive or negative results when 
assessing samples with high background. Second, nucleotide length of the amplified fragments 
can be defined based on size standards, which can be helpful to confirm identification among 
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multiple samples in a same individual. Third, since the GeneScan analysis employs PCR system, 
it requires only a small amount of cell or tissue sample. Finally, it is a rapid and high throughput 
method applicable for large numbers of samples. GeneScan analytical system of antigen 
receptor genes was recently introduced into veterinary medicine and shown to be effective as an 
adjunctive diagnostic tool for detecting clonally expanded lymphoid cells in dogs (Gentilini et 
al., 2009; Keller and Moore, 2012). In addition, multiplex GeneScan analytic system has been 
recently constructed. In this newly developed system, fragments are amplified in small number 
of PCR conditions by using primers with multicolor fluorogenic probe, which is considered to 
be more suitable for clinical settings. 
   The present study was conducted for the purpose of application of multiplex GeneScan 
analysis of antigen receptor gene rearrangements to the clinical settings for the diagnosis and 
further understanding of canine lymphoproliferative diseases. In Chapter 1, association between 
clonal antigen receptor gene rearrangements and histopathological evaluation of endoscopic 
biopsies was investigated in order to understand the value of GeneScan analysis in diagnosing 
gastrointestinal (GI) lymphoma. In Chapter 2, usefulness of GeneScan analysis for detecting 
circulating tumor cells (CTCs) in canine lymphoma was investigated. In Chapter 3, GeneScan 
analysis was applied to distinguish the origin of tumor cells in dogs that developed 2 different 
types of lymphoid neoplasms. 
 7 
 
 
 
 
 
Chapter 1 
 
Association between lymphocyte antigen receptor gene 
rearrangements and histopathological evaluation  
in canine chronic enteropathy 
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ABSTRACT 
   Although definitive diagnosis of chronic enteropathy (CE) and gastrointestinal (GI) 
lymphoma requires histopathological evaluation of the GI tract, these conditions are often still 
difficult to differentiate from each other. Polymerase chain reaction for antigen receptor gene 
rearrangements (PARR) has been applied recently as an adjunctive for diagnosis of lymphoid 
tumors; however, its clinical value in canine CE and GI lymphoma remains unclear. The 
purpose of this study was to investigate the relationship between PARR and histopathological 
diagnosis, degree of enteritis or lymphoma, and long-term prognosis in dogs, in order to 
evaluate the clinical significance of PARR. Endoscopic biopsy specimens obtained from 96 
dogs with chronic enteritis (mild, n = 14; moderate, n = 20; marked, n = 62) and 21 dogs with 
GI lymphoma were used. Clonal rearrangement in PARR was observed in 51% of the animals 
with chronic enteritis; interestingly, it was found in 29% of those with only mild enteritis. In 
dogs with marked enteritis, the rate of clonal rearrangements was higher in those with 
epitheliotropism of lymphocytes than in those without epitheliotropism. The sensitivity of 
PARR in animals with GI lymphoma was 76%. There was no significant prognostic difference 
between chronic enteritis with or without clonal rearrangements. In contrast, dogs 
histopathologically diagnosed with marked enteritis had a significantly shorter survival time 
than did those with mild or moderate enteritis. While the significance of PARR in the diagnosis 
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of GI lymphoma remains uncertain, the pathological roles of clonally expanding lymphocytes in 
canine CE should be investigated further. 
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INTRODUCTION 
   Chronic enteropathy (CE) is one of the common clinical diagnoses in dogs, characterized by 
persistent or recurrent gastrointestinal (GI) symptoms such as diarrhea, vomiting, and weight 
loss. The common causes of CE include food-responsive enteropathy, antibiotic-responsive 
enteropathy, and inflammatory bowel disease (IBD) (German et al., 2003). The diagnosis of 
canine CE requires various diagnostic evaluations in order to rule out other diseases causative of 
chronic GI symptoms, including metabolic diseases, infection, parasitism, or neoplastic diseases 
(Allenspach, 2013). Although the pathogenesis of canine CE is not yet fully elucidated, 
interaction between the intestinal microenvironment (bacterial or dietary antigens), mucosal 
immune system dysfunction, and genetic factors are considered to be involved in its etiology 
(German et al., 2003; Simpson and Jergens, 2011). Therapeutic trials of dietary modification, 
antibiotics, or immunomodulatory agents are needed to improve diagnosis and control of the 
disease (Allenspach, 2013). If animals with the condition are treated appropriately, the 
prognosis of canine CE is relatively favorable, as it has been reported that the 3-year survival 
rate was 97% in food-responsive dogs with diarrhea and 57% in steroid-treated dogs with IBD 
(Allenspach et al., 2007).  
   GI lymphoma should also be taken into consideration in dogs with chronic GI symptoms. 
Although GI lymphoma seems to be less common in dogs than in cats, it accounts for 
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approximately 7% of all canine GI neoplasms (Patnaik et al., 1977). Despite treatment with 
multidrug chemotherapy, the prognosis of dogs with GI lymphoma is usually poor, as median 
survival time was reported to be 77 days (Rassnick et al., 2009). 
   Because of differences in treatment strategies and outcomes, it is essential to distinguish 
between CE and GI lymphoma. As there is no specific laboratory test for differentiating 
between these 2 diseases, GI biopsies are used to make histopathological diagnosis. Flexible 
endoscopy is the preferred method for obtaining specimens as it is less invasive than surgery 
(Washabau et al., 2010). However, as endoscopically obtained tissues are often limited to 
mucosa, this can lead to pathologists overlooking cases of lymphoma, since this condition can 
involve transmural expansion of neoplastic cells. In addition, GI lymphoma is frequently 
accompanied by infiltration of inflammatory lymphocytes and plasma cells that can cause 
misdiagnosis of lymphocytic-plasmacytic enteritis (Kleinschmidt et al., 2006). 
   Since its advent, polymerase chain reaction (PCR) for antigen receptor gene rearrangements 
(PARR) has been introduced into veterinary practice as a useful adjunctive for the diagnosis of 
lymphoma. It has a high accuracy for the detection of clonal lymphocytes, and its sensitivity in 
diagnosing lymphoid malignancies was reported to be more than 90% (Burnett et al., 2003; 
Gentilini et al., 2009). There are several studies on the application of PARR in GI biopsy 
specimens. One of these reports suggested that PARR was a useful diagnostic tool for detecting 
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latent GI lymphoma, which cannot be histopathologically diagnosed using endoscopic biopsy 
specimens (Kaneko et al., 2009). In another study, the sensitivity of PARR in diagnosing GI 
lymphoma was reported to be 66.7%, which was lower than that for lymphoma affecting other 
anatomical sites; thus, it may be useful for detecting lymphoma when combined with 
histopathological examination (Fukushima et al., 2009). On the other hand, a more recent study 
indicated that clonal lymphocytic infiltration was also detected in the GI tract of dogs with IBD, 
and reduced diversity of lymphocytic infiltrates significantly correlated with one-year survival 
rate (Olivero et al., 2011). 
   The purpose of this study was to investigate the relationship between PARR and 
histopathological diagnosis, degree of enteritis or lymphoma, and long-term prognosis in dogs 
with persistent or recurrent GI symptoms, in order to evaluate the clinical significance of 
PARR. 
 
MATERIALS AND METHODS 
Cases  
   Medical records of dogs investigated for chronic GI diseases at the Veterinary Medical 
Center of the University of Tokyo (from May 2011 to December 2012) and the Japan Small 
Animal Medical Center (from April 2012 to March 2013) were reviewed retrospectively. The 
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following inclusion criteria were used: (1) a history of chronic GI signs with a duration of >3 
weeks and/or hypoalbuminemia (<2.7 g/dL); (2) exclusion of other causes of chronic GI signs 
(metabolic diseases, infection, and parasitism) or hypoalbuminemia (hepatic disease, renal 
disease, and blood loss) by complete blood cell count, serum biochemistry, urinalysis, fecal 
examination for parasites and bacteria, and abdominal ultrasonography; (3) availability of 
histopathological evaluation of mucosal specimens obtained via upper and/or lower GI tract 
endoscopic examination; and (4) availability of genomic DNA extracted from duodenal mucosa 
obtained via endoscopy. Food-responsive enteropathy and antibiotic-responsive enteropathy 
were not ruled out before endoscopic examination if worsening of clinical signs was observed in 
animals with suspected neoplastic disease. Cases were included regardless of treatments given. 
   According to the inclusion criteria, the medical records of 120 dogs were reviewed. Three of 
the animals were histopathologically diagnosed with gastric adenocarcinoma and so were 
excluded from the present study. Of the remaining 117 dogs, 96 were diagnosed with chronic 
enteritis and 21 were diagnosed with GI lymphoma by histopathological evaluation. Cases were 
excluded from survival analysis if concurrent neoplastic diseases other than GI lymphoma were 
confirmed. The referring veterinarians or the owners were contacted to obtain follow-up data.  
 
Histopathology 
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   Endoscopy of the upper GI tract was performed in all dogs, and 6 mucosal biopsy specimens 
were collected from both the stomach and the duodenum. In cases undergoing lower GI tract 
endoscopy, 6 mucosal biopsies were also obtained from both the ileum and the colon. Tissue 
samples were submitted for histopathological examination according to the method described in 
a previous report (Washabau et al., 2010). Biopsy specimens were oriented with the submucosal 
side facing downwards and the villi side facing upwards, so that the entire depth of the mucosa 
could be evaluated. The specimens were then placed in histopathological cassettes and fixed in 
10% formalin for 48 h, processed and paraffin embedded, cut into sections, and stained with 
hematoxylin and eosin (HE). Histopathological diagnoses made from HE-stained sections were 
reviewed in the archives, and cases were classified as described below. Final diagnoses were 
defined as the most severe histopathological classification for all of the bioptic sites in each case 
of chronic enteritis. GI lymphoma was diagnosed when at least one of the sites was diagnosed 
with lymphoma. 
   Chronic enteritis was diagnosed according to the histopathological standards for endoscopic 
biopsy samples proposed by the World Small Animal Veterinary Association (WSAVA) (Day 
et al., 2008). Microscopic inflammatory changes defined by morphological abnormalities and 
inflammatory cell infiltration were assessed for each of the anatomical regions, and each of the 
cases was categorized as (1) normal, (2) mild, (3) moderate, or (4) marked, based on the grade 
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of histopathological severity. For chronic enteritis with marked changes, infiltration of 
intraepithelial lymphocytes was evaluated and classified into two groups according to its 
severity: epitheliotropism [−] or epitheliotropism [+]. This classification was provisionally 
performed in order to attempt to distinguish lymphoma (small cell lymphoma, if it exists) from 
chronic inflammation, because the increase observed in intraepithelial lymphocytes was found 
to be significantly different between cases of GI lymphoma and IBD in cats (Kiupel et al., 
2011). 
   GI lymphoma was diagnosed histopathologically based on severe infiltration of large 
lymphoid cells (nuclear diameter > 2 blood cell diameters) associated with mucosal injury, in 
line with the previous report on feline GI lymphoma of large cell type (Moore et al., 2012). 
 
Polymerase Chain Reaction for Antigen Receptor Gene Rearrangements 
   Genomic DNA was extracted from endoscopically obtained duodenal tissues from each of 
the animals using a QIAamp DNA Blood Mini Kit (Qiagen, Valencia, CA), according the 
manufacturer’s instructions. Rearrangements of the IgH/TCRγ genes were assessed by 
amplifying complementarity determining region 3 (CDR3) to evaluate lymphocyte clonality 
using primers derived from V segments and J segments of each of the genes. Two control genes 
(IgM C region and HGF) were also amplified. All of the forward primers were labeled with 
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fluorescent dyes at the 5’ end. PCR reactions were carried out in a final volume of 25 µL. The 
PCR mixture was composed of 1 × Amplitaq Gold 360 Master Mix (Applied Biosystems, Foster 
City, CA), forward primer (200 nM), reverse primer (200 nM), and 100 ng of DNA template. 
Cycle conditions consisted of an initial denaturation and enzyme activation step at 95°C for 5 
min, followed by 40 cycles of denaturation at 94°C for 15 sec, annealing at 62°C or 56°C for 30 
sec and extension at 72°C for 30 sec. A final extension at 72°C for 30 min was included in 6 of 
the 7 reactions. Each PCR reaction was performed in duplicate. GeneScan analysis was carried 
out on the ABI 3130xl Genetic Analyzer (Applied Biosystems) as a multiplex run. One 
microliter of PCR product mixture diluted 40-fold was combined with 8.5 µL of Hi-Di 
formamide (Applied Biosystems) and 0.5 µL of 600 LIZ size standard (Applied Biosystems) in 
an optical 96-well plate. The products were denatured at 95°C for 5 min, immediately placed on 
ice for 15 min, and then subjected to the analysis. Resulting data were analyzed with Peak 
scanner software (Applied Biosystems). Distinct peaks that were at least 2-fold higher than 
other background peaks were judged to show the presence of clonally expanded lymphoid cells. 
Presence of a single or two peaks was interpreted as the clonal rearrangements. 
 
Statistical Analysis 
   Differences in survival time according to the results of PARR and histopathological 
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evaluation were analyzed using the Kaplan-Meier method and log-rank test. 
   A P value <0.05 was defined as statistically significant. Significance level was corrected by 
Bonferroni’s method for multiple comparison. 
 
RESULTS 
Signalment 
   According to the inclusion criteria, 117 dogs were included in this study. Dogs with chronic 
enteritis (n = 96) consisted of 56 males (neutered, 32) and 40 females (neutered, 22). The 
median age at the time of diagnosis was 7.9 years (range, 1.9−14.3 years). The dog breeds were 
as follows: Miniature Dachshund (n = 11), Shiba (n = 9), Yorkshire Terrier (n = 9), Chihuahua 
(n = 6), French Bulldog (n = 6), Toy Poodle (n = 6), Maltese (n = 4), Pomeranian (n = 4), 
Boston Terrier (n = 3), Pug (n = 3), and others (n = 35). 
   Dogs with GI lymphoma (n = 21) consisted of 9 males (neutered, 4) and 12 females 
(neutered, 7). The median age was 10.3 years (range, 5.5−15.1 years). The dog breeds were as 
follows: Miniature Dachshund (n = 5), Pug (n = 4), Shiba (n = 3), and others (n = 9). 
 
Histopathological Evaluation 
   According to the WSAVA guidelines, the 96 dogs with chronic enteritis were classified into 
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mild (n = 14), moderate (n = 20), and marked (n = 62) categories based on the histopathological 
severity of disease (Figs. 1-1,2 and 3). In addition, cases of marked enteritis were classified as 
epitheliotropism [−] (n = 21) or epitheliotropism [+] (n = 41) based on the severity of 
intraepithelial lymphocytic infiltration. Intraepithelial lymphocytes were found in clusters or as 
diffuse infiltrates in epithelia (Fig. 1-3b). In GI lymphoma (n = 21), the lamina propria showed 
diffuse infiltration by large lymphoid cells accompanied by alterations of the mucosal 
architecture including marked villous blunting and epithelial injury (Fig. 1-4). 
 
Association between PARR and Histopathology 
   The results of PARR analysis are shown in Table 1-1. Clonal rearrangements of antigen 
receptor genes were detected in 49 of 96 dogs (51%) with chronic enteritis and 16 of 21 dogs 
(76%) with GI lymphoma. With respect to histopathological severity, clonal rearrangements 
were detected in 4 of 14 dogs (29%) with mild enteritis, 8 of 20 dogs (40%) with moderate 
enteritis, 10 of 21 dogs (48%) with marked enteritis classified as epitheliotropism [−], and 27 of 
41 dogs (66%) with marked enteritis classified as epitheliotropism [+]. 
 
Survival Analysis 
   Survival time in dogs with chronic enteritis showing clonal rearrangements was not 
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significantly different from that in dogs without clonal rearrangements in chronic enteritis (P = 
0.35) (Fig. 1-5).  
   The results of survival analysis according to histopathological classification are shown in 
Figure 1-6. Survival time in dogs with marked enteritis was significantly shorter than that in 
dogs with mild or moderate enteritis (P = 0.0088). Survival time in dogs with GI lymphoma was 
significantly shorter than that in those with chronic enteritis, regardless of histopathological 
severity (P <0.0001). The median survival time was 61 days in dogs with GI lymphoma and 542 
days in dogs with marked enteritis. The median survival time was not defined in all of the dogs 
with chronic enteritis as a whole. There was no significant difference in survival time between 
marked enteritis with and without epitheliotropism (P = 0.61) or clonal rearrangements (P 
=0.42) (data not shown).  
 
DISCUSSION 
   In the current study, I assessed the association between lymphocyte antigen receptor gene 
rearrangements and histopathological evaluation in dogs with CE. The findings in this study 
revealed that even 29% of dogs with mild enteritis had clonal rearrangements. Moreover, there 
was no significant association between the results of PARR analysis and long-term prognosis in 
CE. Meanwhile, the significance of PARR in the diagnosis of canine GI lymphoma remains 
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questionable. 
   There are several possible explanations for the clonal rearrangements seen in dogs 
diagnosed with chronic enteritis. First, persistent stimulation by specific antigens may have 
caused monoclonal proliferation of lymphocytes. PARR has been reported to have high 
sensitivity for detection of lymphoid tumors, while studies focusing on the specificity of this 
method have not yet been published in veterinary medicine. In humans, monoclonality is also 
detected in benign skin lesions (drug eruption, insect bite reactions, and Borreliosis), some 
kinds of food allergy, Helicobacter pylori gastritis, various autoimmune diseases, and viral 
infections (Bakakos et al., 2001; Boer et al., 2008; Calvert et al., 1996; Engels et al., 2007; 
Hoeve et al., 2000). Furthermore, monoclonal or oligoclonal repertoires of antigen receptor 
genes in ehrlichiosis and leishmaniasis have also been reported in dogs (Burnett et al., 2003; 
Gentilini et al., 2009). Second, GI lymphoma may have been overlooked by histopathological 
examination, because observation was limited to the mucosal architecture since only endoscopic 
biopsy specimens were obtained in the present study. Full-thickness biopsy enables pathologists 
to evaluate transmural alterations and has diagnostic value for GI lymphoma comprising 
transmural lesions (Evans et al., 2006; Kleinschmidt et al., 2006). However, this explanation is 
less likely, because no significant difference in long-term prognosis due to the results of PARR 
in CE was observed.  
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   An additional explanation is that small cell GI lymphoma could be detected by PARR. 
T-cell lymphoma of small cell type is the dominant GI lymphoma found in cats and is 
characterized by increased infiltration of mature-appearing lymphocytes into the mucosa 
(Moore et al., 2012). As their histological characteristics are similar to each other, small cell GI 
lymphoma is often difficult to differentiate from severe enteritis (Kiupel et al., 2011). In 
contrast, there is no extensive study clearly describing this entity in dogs thus far. Since an 
increase in intraepithelial lymphocytes is one of the significant histopathological findings that 
differentiates small cell lymphoma from enteritis in cats (Kiupel et al., 2011), I compared clonal 
rearrangements in cases of severe enteritis with and without epitheliotropism. The results 
showed that severe enteritis with epitheliotropism had a higher detection rate of PARR than 
cases without epitheliotropism. On the other hand, neither epitheliotropism nor PARR had a 
significant prognostic association in dogs with severe enteritis. The prognosis of cats with small 
cell GI lymphoma is favorable; median survival time has been reported to be 704 days (Kiselow 
et al., 2008), and median remission time was 786 days when animals were treated with 
prednisolone and chlorambucil (Stein et al., 2010). Considering the prognosis of cats with small 
cell GI lymphoma, the possibility remains that the investigation period of the present study was 
not long enough to distinguish between small cell GI lymphoma and chronic enteritis. Further 
studies are warranted in order to validate the presence and diagnostic definition of small cell GI 
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lymphoma in dogs.  
   Association between prognosis or clinical findings and histopathological severity has been 
reported to be equivocal so far when using endoscopic biopsy specimens (Allenspach et al., 
2007; Garcia-Sancho et al., 2007; Schreiner et al., 2008), which may result in part from a lack 
of standardized histological scoring systems and guidelines for sample submission technique 
(Willard et al., 2008). In contrast to the previous studies, the present study revealed that the 
histopathological severity of the intestinal mucosa was significantly associated with prognosis 
in canine CE. In the present study, the procedure for biopsy, sample submission, and 
histopathological evaluation of enteritis was based on the WSAVA guidelines (Washabau et al., 
2010). Considering that a significant association between histopathological severity and 
prognosis was observed in this study, it is reasonable to recommend following these 
standardized criteria for histological examination in canine CE. However, the differences 
between enteritis and GI lymphoma are not described in the WSAVA guidelines; thus, further 
investigation of the diagnostic criteria of small cell GI lymphoma in particular is needed.  
   In the present study, the rate of PARR was 76% in GI lymphoma, which was higher than 
that of enteritis of any severity. However, this rate was lower than that found for lymphoma 
affecting other anatomical sites, similar to the results of a previous study (Fukushima et al., 
2009). There are several explanations for why the sensitivity of PARR was lower in GI 
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lymphoma compared with lymphoma affecting other sites. First, as GI lymphoma can have a 
patchy distribution, differences in biopsy site may lead to inconsistencies between PARR and 
histopathological examination. Second, the primers used in this study did not cover all of the 
possible rearrangements of antigen receptor genes. Third, as the primers were for IgH and TCRγ, 
they could not detect non-T, non-B lymphoma. Considering the highly positive rate of PARR 
when all cases of enteritis were taken together, the detection of a clonal population of 
lymphocytes does not always confirm the diagnosis of lymphoma, nor does the absence of such 
a population indicate benignity.  
   In conclusion, clonal lymphocytic expansion was detected in about half of the animals with 
chronic enteritis in the present study. With regard to clinical applications, interpretation of 
PARR using intestinal biopsy specimens is still controversial, and further studies are needed to 
clarify its clinical significance. On the other hand, the present study revealed a significant 
association between histopathological severity and survival time in canine CE for the first time. 
It may be important to evaluate the histopathological severity in chronic enteritis in order for 
clinicians to predict a patient’s prognosis. While the significance of PARR in the diagnosis of 
GI lymphoma remains uncertain, the pathological roles of clonally expanding lymphocytes in 
canine CE should be investigated further. 
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Table 1-1. Detection rate of clonal rearrangements of antigen receptor genes by histopathological category. 
Histopathological diagnosis (n) 
Total number positive for  
clonal rearrangements (%) 
Clonally rearranged gene(s) 
TCRγ a IgH b  TCRγ + IgH 
Chronic enteritis (96) 49 (51%) 40 3 6 
Mild (14) 4 (29%) 4 0 0 
Moderate (20) 8 (40%) 7 0 1 
Marked (62) 37 (60%) 29 3 5 
 Epitheliotropism [-] (21) 10 (48%) 8 0 2 
Epitheliotropism [+] (41) 27 (66%) 21 3 3 
GI c lymphoma (21) 16 (76%) 13 2 1 
a TCRγ, T cell receptor gamma chain gene; b IgH, immunoglobulin heavy chain gene; c GI, gastrointestinal.  
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Figs.1-1. Section of duodenum mucosa from a dog with mild chronic enteritis stained with 
hematoxylin and eosin. Inflammatory changes are mild and the mucosal architecture is 
relatively preserved (a). There is a mild increase in intraepithelial and lamina propria 
lymphocytes (b). 
 
 
Figs. 1-2. Section of duodenum mucosa from a dog with moderate chronic enteritis stained with 
hematoxylin and eosin. Moderate crypt distention and lacteal dilation are observed (a). There is 
a mild increase in intraepithelial and lamina propria lymphocytes (b). 
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Figs. 1-3. Section of duodenum mucosa from a dog with marked enteritis stained with 
hematoxylin and eosin. Marked villous blunting and moderate lacteal dilation are observed (a). 
Small and mature-appearing lymphocytes heavily infiltrate into the epithelia and lamina propria. 
This case was classified as epitheliotropism [+] (b). 
 
 
Figs. 1-4. Section of duodenum mucosa from a dog with intestinal lymphoma stained with 
hematoxylin and eosin. The mucosal architecture is altered by villous blunting with epithelial 
injury (a). Diffuse infiltration of pleomorphic large lymphoid cells with multiple nucleoli can be 
observed (b). 
 
 
 
 
 
 27 
 
 
Fig. 1-5. Kaplan-Meier curves for dogs with chronic enteritis comparing animals with and 
without clonal rearrangements of antigen receptor genes (49 and 47 dogs, respectively). 
Survival time was not significantly different between dogs with and without clonal 
rearrangements (P = 0.35). 
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Fig. 1-6. Kaplan-Meier curves for dogs with mild/moderate chronic enteritis, marked enteritis, 
and gastrointestinal (GI) lymphoma (34, 62, and 21 dogs, respectively). Survival time in dogs 
with mild or moderate enteritis was significantly longer than that in animals with marked 
enteritis (P = 0.0088). Survival time in dogs with chronic enteritis was significantly longer than 
that in animals with GI lymphoma (P <0.0001). 
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Chapter 2 
 
Detection of circulating tumor cells using GeneScan analysis of 
antigen receptor gene rearrangements in canine lymphoma 
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ABSTRACT 
   Detection of circulating tumor cells (CTCs) is known to be useful in predicting relapse, 
prognosis, or evaluating treatment efficacy in lymphomas both in humans and dogs. Although 
several molecular techniques to detect CTCs have been proposed, each method has some 
limitations. The purpose of this study is to analyze the ability of GeneScan in detecting CTCs, 
and to investigate the prognostic significance depending on CTCs status in canine lymphoma. 
Samples from the primary lesions and peripheral blood mononuclear cells (PBMCs) were 
obtained in 32 dogs with lymphoma at the initial diagnosis. All the samples were subjected to 
polymerase chain reaction (PCR) for antigen receptor gene rearrangements (PARR) and 
analyzed by GeneScan. As a result, in 13 of the 17 dogs (76%) with high-grade multicentric 
lymphoma, all of the 3 dogs with low-grade multicentric lymphoma, and 4 of the 12 dogs (33%) 
with GI lymphoma, PARR results were positive and identical size of PCR products were 
detected between the primary lesions and PBMCs. Identical sequences of the PCR products 
were confirmed between the lesional sample and PBMCs, indicating the presence of CTCs. The 
GeneScan analysis employed in this study would facilitate the study on the clinical significance 
of CTCs in dogs with lymphoma. 
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INTRODUCTION 
   Lymphoma is one of the most common haematopoietic neoplasms in dogs with incidence of 
13-24% among all canine neoplasms (Dorn et al., 1970). Multidrug chemotherapy based on 
CHOP (prednisolone, doxorubicin, vincristine, and cyclophosphamide) protocol has been 
standardized regimen in canine lymphoma, showing complete remission (CR) rates more than 
80% (Burton et al., 2013; Garrett et al., 2002; Keller et al., 1993). However, most of the dogs 
experience relapse and die from disease progression.  
   For predicting outcome and monitoring of the disease, detection of circulating tumor cells 
(CTCs) can provide valuable information. CTCs are defined as tumor cells in the peripheral 
blood derived from the primary or secondary tumor lesion. CTCs are the cause of disseminated 
malignant cells to other distant organs and eventually become clinically evident as metastatic 
tumors (Joosse et al., 2014). In addition, CTCs which escape anti-cancer therapy are considered 
to be the source of relapse (Kern et al., 2008; Pott et al., 2006). Assessment of CTCs after 
chemotherapy is known to be useful for the prediction of the prognosis and the disease relapse, 
as well as monitoring the treatment efficacy in canine lymphoma (Sato et al., 2011a; Sato et al., 
2011b; Sato et al., 2013; Yamazaki et al., 2010).  
   Detection of neoplastic cells by microscopic evaluation of peripheral blood smear is 
available in routine laboratory examination. However, it is less objective which can lead to 
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misjudgments when peripheral blood involves only small number of malignant cells. Therefore, 
several molecular techniques for detecting CTCs have been recently proposed. PCR for antigen 
receptor gene rearrangements (PARR) is reported to be a reliable and sensitive method to detect 
CTCs (Keller et al., 2004; Lana et al., 2006; Thilakaratne et al., 2010). Conventional method of 
PARR is generally conducted by using consensus primers followed by separation of nucleotide 
fragments using polyacryl amide gel electrophoresis (PAGE). However, the positive result does 
not always indicate the presence of CTCs especially in the cases of inflammatory diseases, since 
these primers were not tumor-specific. 
   Recently, quantitative assessment method of CTCs in canine lymphoma by real-time PCR 
was established (Yamazaki et al., 2008). Since antigen receptor genes were amplified by 
tumor-specific primers, this method is highly accurate. In addition, it is sensitive enough to 
detect small number of residual tumor cells in clinical remission, which is called minimal 
residual disease (MRD). On the other hand; however, the establishment of tailored assay for 
each individual is cumbersome and expensive, which is difficult to be applied in routine clinical 
settings.  
   Recently, GeneScan analysis was introduced to examine the clonal expansion of lymphoid 
cells in dogs with lymphoproliferative disorders (Gentilini et al., 2009; Keller and Moore, 2012). 
One of the advantages of GeneScan analysis over conventional PAGE method is that nucleotide 
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length of the amplified fragments can be defined based on size standards, which can be helpful 
to confirm identification among multiple samples in a same individual. Therefore, I 
hypothesized that even consensus primers can strongly suggest the existence of CTCs if PCR 
products with identical nucleotide length were detected between the primary tumors and 
peripheral blood by means of GeneScan analysis. In addition, most of the studies on CTCs 
detection in canine lymphoma have been focused on multicentric type. Therefore, in this study, 
GemeScan analysis was used to examine the presence of CTCs in gastrointestinal (GI) 
lymphoma as well as multicentric lymphoma in dogs. 
   The purpose of this study was to investigate the usefulness of GeneScan analysis in 
detecting CTCs, and prognostic significance of CTCs at the time of diagnosis in canine 
lymphoma. 
 
MATERIALS AND METHODS 
Cases 
   Medical records of dogs diagnosed with lymphoma at the Medical Center of the University 
of Tokyo (VMC-UT) from June 2011 to November 2013 were reviewed retrospectively. The 
following inclusion criteria were used: (1) Clonal rearrangements of T-cell receptor γ chain gene 
(TCRγ) and/or immunoglobulin heavy chain gene (IgH) were detected in the primary lesions; 
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(2) Genomic DNA extracted from both primary lesions and corresponding peripheral blood 
mononuclear cells (PBMCs) obtained at the time of diagnosis were available; (3) Absence of 
clear evidence of concurrent inflammatory diseases including infection, parasitism, and 
autoimmune diseases at the time of diagnosis. 
   According to the inclusion criteria, 17 dogs with high-grade multicentric lymphoma, 3 dogs 
with low-grade multicentric lymphoma, 12 dogs with GI lymphoma, were included in this 
study.  
   All dogs with high-grade multicentric lymphoma and one dog with GI lymphoma were 
diagnosed by cytology of enlarged superficial lymph node and intestinal mass, respectively, 
based on updated Kiel classification (Fournel-Fleury et al., 1997). Remaining 11 dogs with GI 
lymphoma were histopathologically diagnosed based on severe infiltration of large lymphoid 
cells (nuclear diameter > 2 blood cell diameters) associated with intestinal mucosal injury. 
Three dogs with low-grade multicentric lymphoma were histopathologically classified into 
T-zone lymphoma based on the World Health Organization (WHO) classification of canine 
malignant lymphoma (Valli et al., 2011). 
 
Samples 
   Tumor cells of enlarged superficial lymph nodes were obtained by fine needle aspiration in 
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all dogs with high-grade multicentric lymphoma. In dogs with low-grade multicentric 
lymphoma, enlarged superficial lymph nodes were surgically resected for histopathological 
evaluation. Intestinal biopsies were obtained by flexible endoscopy in dogs with GI lymphoma 
except for 2 dogs. Surgical resection or fine needle aspiration were performed to obtain the 
samples of intestinal mass in the remaining 2 dogs with GI lymphoma.  
   Peripheral blood (3 mL) was collected in EDTA-treated tubes at the time of initial diagnosis 
and PBMCs were isolated by density gradient centrifugation with Ficoll-Paque PLUS (specific 
gravity, 1.077; GE Healthcare, Buckinghamshire, UK). 
 
DNA Extraction 
   Genomic DNA was extracted from both primary lesions and PBMCs using a QIAamp DNA 
Blood Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions, and 
subjected for PARR and sequencing.  
 
PCR for Antigen Receptor Gene Rearrangements 
   Rearrangements of the IgH/TCRγ genes for all specimens were assessed by GeneScan 
analytical system to determine lymphocyte clonality as described in the Materials and Methods 
section in Chapter 1. 
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Cloning and Sequencing of Complementary Determining Region 3 (CDR3) 
   PCR products amplified by the method described above were cloned in the pGEM T-Easy 
Vector using the TA cloning system (Promega Corporation, Madison, WI) according to the 
manufacturer’s instructions. DNA Sequencing was performed from the plasmid preparation 
using a BigDye terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) 
and Applied Biosystems 3130xl genetic analyzer (Applied Biosystems).  
 
Statistical Analysis 
   Differences in survival time between dogs with and without detectable CTCs were analyzed 
using the Kaplan-Meier method and log-rank test. A P value <0.05 was defined as statistically 
significant.  
 
RESULTS 
Signalment 
   According to the inclusion criteria, 32 dogs were included in this study. Dogs with 
high-grade multicentric lymphoma (n = 17) consisted of 7 males (neutered, 6) and 10 females 
(neutered, 2). The median age at the time of diagnosis was 9.1 years (range, 2.8−13.4 years). 
 37 
The dog breeds were as follows: Pembroke Welsh Corgi (n = 4), French Bulldog (n = 3), 
Miniature Schnauzer (n = 3), Miniature Dachshund (n = 2), Shi Zhu (n = 2), Labrador Retriever 
(n =1), Rough Collie (n =1), and West Highland White Terrier (n = 1).  
   Dogs with low-grade multicentric lymphoma (n = 3) consisted of 1 male and 2 females 
(neutered, 2). The age at the time of diagnosis was ranged from 11.7 to 12.8 years. The dog 
breeds were as follows: Pembroke Welsh Corgi (n =1), Pomeranian (n =1), and Shi Zhu (n =1).  
   Dogs with GI lymphoma (n =12) consisted of 5 males (neutered, 2) and 7 females (neutered, 
6). The median age at the time of diagnosis was 9.7 years (range, 7.6 – 15.1 years). The dog 
breeds were as follows: Pug (n = 4), Miniature Dachshund (n = 2), Shiba (n = 2), Bichon Frise 
(n = 1), Chihuahua (n =1), Jack Russell Terrier (n = 1), and Maltese (n = 1). 
 
GeneScan Analysis in Primary Tumors and PBMCs 
   The results of GeneScan analysis are shown in Fig. 2-1. The nucleotide lengths of clonal 
PCR products are identical between primary lesions and corresponding PBMCs in 13 of 17 dogs 
(76%) with high-grade multicentric lymphoma, 3 of 3 dogs (100%) with low-grade multicentric 
lymphoma, and 4 of 12 dogs (33%) with GI lymphoma. Interestingly, in 5 dogs (42%) with GI 
lymphoma, PARR was positive; however, the nucleotide lengths of the PCR products were 
different between primary lesions and PBMCs. 
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CDR3 Sequence 
   To confirm the detection of CTCs, two cases (one each from dogs with high-grade 
multicentric lymphoma and GI lymphoma) with identical size of PCR products between 
primary lesions and PBMCs were selected and CDR3 sequences were analyzed (Fig. 2-2a,b). 
CDR3 sequences of PBMCs were identical to that of the primary lesions in 7 of 7 clones in a 
case with high-grade multicentric lymphoma, and 5 of 12 clones in a case with GI lymphoma. 
In addition, one case with GI lymphoma which had PCR products with different size between 
the samples was also subjected for CDR3 sequencing (Fig. 2-2c). No sequence which was 
identical to the duodenal samples was detected from 12 clones analyzed from PBMCs. 
 
Survival Analysis 
   The results of survival analysis are shown in Fig. 2-3. There was no significant difference in 
survival time between dogs with and without detectable CTCs at the time of diagnosis in 
multicentric lymphoma (P = 0.28) (Fig. 2-3a). Median survival times were 201 and 345.5 days 
in dogs with and without detectable CTCs at diagnosis, respectively. Survival time was 
significantly shorter in dogs without detectable CTCs compared with detectable CTCs in GI 
lymphoma (P = 0.037) (Fig. 2-3b). Median survival time was 206 and 57 days in dogs with and 
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without detectable CTCs, respectively. 
 
DISCUSSION 
   In current study, usefulness of GeneScan analysis in detecting CTCs in canine lymphoma 
was investigated. PCR products with identical size between lymph node and peripheral blood 
were detected in 80% of dogs with multicentric lymphoma and 33% of dogs with GI lymphoma 
which were indicative of the presence of CTCs. 
   Detection rate of CTCs in dogs with GI lymphoma was lower than that in dogs with 
multicentric lymphoma. CTCs level in peripheral blood are reported to be observed in parallel 
with the changes in the total lymph node volumes, indicating CTCs volume reflect tumor 
burden in one’s body (Yamazaki et al., 2008). Therefore, it is considered that total tumor burden 
was small in GI lymphoma compared with multicentric lymphoma at the time of diagnosis. 
Since even localized tumor cells in GI tract likely to result in readily identifiable symptoms, 
patients at the time of diagnosis might be relatively in early tumor stage. Another possible 
explanation is that tumor cells in GI lymphoma would tend to localize into epithelium rather 
than into circulation. Certain type of T-cells in GI tract are known to have nature of homing to 
epithelium (Luckschander et al., 2009). It is regulated by interaction between lymphocytes and 
enterocytes, and several molecules associated with epithelial homing were identified in human 
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medicine (Johansson-Lindbom and Agace, 2007). The expression of CD103, which is one of the 
homing associated molecule, was previously demonstrated in epitheliotropic T-cell lymphoma 
in cats (Roccabianca et al., 2006). Since the epithelial tissues were heavily injured in GI 
lymphoma, epitheliotriopism is not always evident in all the cases from histopathological 
examination. However the clonal rearrangements were detected in TCRγ in most of the dogs 
with GI lymphoma, tumor cells are presumed to be consist of T-cell population. Behavioral 
difference between tumor cells in GI lymphoma and multicentric lymphoma has to be 
investigated further. 
   Survival time was not significantly different between dogs with and without detectable 
CTCs at the initial diagnosis of multicentric lymphoma. It was previously reported that there is 
no prognostic significance in the results of conventional PARR using consensus primers or the 
amount of CTCs using tumor-specific primers at the initial diagnosis in canine multicentric 
lymphoma (Lana et al., 2006; Sato et al., 2013). The finding of the present study was consistent 
with the previous reports. In previous studies, assessment of CTCs is reported to be useful for 
prognostic marker in early phase of treatment, prediction of the disease relapse, and monitoring 
the treatment efficacy in canine lymphoma rather than biomarkers at the time of diagnosis (Sato 
et al., 2011a; Sato et al., 2011b; Sato et al., 2013).  
   I investigated survival time also in dogs with GI lymphoma, and unexpectedly it was 
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significantly shorter in dogs without detectable CTCs compared with detectable CTCs. Since 
our study population was small, definitive conclusion can not made from this result. Therefore, 
value of GeneScan CTC monitoring have to be further investigated in larger population. 
   Interestingly, clonally expanded lymphocyte populations which were different from 
lymphoma clone were detected in high proportion of dogs with GI lymphoma. In humans, some 
kinds of autoimmune diseases and food allergy result in clonal expansion of lymphocytes in 
peripheral blood (Bakakos et al., 2001). Furthermore, ehrlichiosis can be cause of positive 
results in PARR of peripheral blood in dogs (Burnett et al., 2003). Although dogs with 
inflammatory diseases such as inflammatory bowel disease (IBD) were tried to be excluded, 
inflammatory changes of the intestine are often accompanied with GI lymphoma. Therefore, GI 
lymphoma cases concomitant with chronic enteritis were possibly included in the patient group 
in this study, and it may be one possible reason of this phenomenon. Some of the confusing 
results were demonstrated also in other study conducting PARR in canine lymphoma 
(Thilakaratne et al., 2010); while clonality of TCR was detected in peripheral blood, clonality of 
IgH was detected in lymph node at the same time. In addition, one dog did not have clonality 
rearrangements from lymph node, but clonal IgH rearrangement was detected from peripheral 
blood. Taken together, positive results do not always indicate the presence of CTCs when using 
consensus primers in PARR. Therefore, GeneScan analysis has an advantage over conventional 
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method from the aspects that it can suggest more strongly of CTCs by comparing the size of 
PCR products in primary lesions with peripheral blood even in use of consensus primers. 
   In conclusion, I revealed that 80% of dogs with multicentric lymphoma and 33% of dogs 
with GI lymphoma were shown to have CTCs as detected by GeneScan analysis. Clinical 
significance of monitoring CTCs on prognosis or relapse prediction by using this novel 
technology has to be investigated further. 
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Fig. 2-1. Proportion of cases with identical length of clonal PCR products between primary 
lesions and peripheral blood mononuclear cells (PBMCs), indicating the presence of circulating 
tumor cells (CTCs) by GeneScan analysis. 13/17 (76%) dogs with high-grade multicentric 
lymphoma, and 3/3 (100%) dogs with low-grade lymphoma, and 4/12 (33%) dogs with GI 
lymphoma had detectable CTCs. 
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Figs. 2-2. Representative results of GeneScan analysis and comparison of sequence of the PCR 
products between the primary lesions and peripheral blood mononuclear cells (PBMCs). The 
line in the top of each alignment show the major sequence from the primary lesions, and 
alignment below are the sequence analyzed from PBMCs. Background of different residues are 
colored. Sequence identification between corresponding samples was confirmed in one each of 
the cases of high-grade multicentric lymphoma (a) and GI lymphoma (b), which were detected 
identical size of clonal products by GeneScan analysis. Meanwhile, Only different sequences 
were detected from PBMCs in one case of GI lymphoma, which were detected different size of 
clonal PCR products by GeneScan analysis (c). IgH, immunoglobulin heavy chain gene; 
TCRγ, T cell receptor gamma chain gene; LN, lymph node; PBMCs, peripheral blood 
mononuclear cells; F primer, forward primer; R primer, reverse primer. 
 
 
 
 
 
 
 
 
 
 
 
 
 46 
 
 
 
Figs. 2-3. Kaplan-Meier curves for dogs with and without detectable CTCs in high-grade 
multicentric lymphoma (13 and 4 dogs, respectively) (a) and GI lymphoma (4 and 8 dogs, 
respectively) (b). Survival time was not significantly different between the 2 groups in 
high-grade multicentric lymphoma (P = 0.28). The survival time was significantly shorter in 
dogs without detectable CTCs compared with dogs with detectable CTCs (P = 0.037). 
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Chapter 3 
 
GeneScan analysis for the differentiation of clonal origin  
of cells in dogs that developed two different types  
of lymphoid malignancies 
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ABSTRACT 
   Development of secondary high-grade lymphoma from indolent lymphoid malignancies has 
been reported in humans, commonly referred to Richter’s syndrome. Similar conditions have 
been also reported in dogs. Herein, we used GeneScan analysis to differentiate the clonal origin 
of cells in dogs that developed 2 different types of lymphoid malignancies. One dog with 
splenic marginal zone lymphoma (MZL), a dog with B-cell chronic lymphocytic leukemia 
(B-CLL), and 2 dogs diagnosed with T-zone lymphoma (TZL) developed secondary high-grade 
B-cell lymphoma (diffuse large B-cell lymphoma, DLBCL). One dog with an initial diagnosis 
of nodal MZL developed follicular center cell lymphoma (FCCL) III more than 1 year after the 
initial diagnosis. GeneScan analysis revealed a single peak of the IgH gene with the same length 
in both the primary (MZL and B-CLL) and secondary tumors in 3 dogs, indicating that the 
secondary tumors evolved from the pre-existing primary indolent neoplasm clone. A single 
TCRγ peak was identified in the 2 TZL samples. However, subsequent DLBCL samples from 
the same 2 dogs revealed a single peak of the IgH gene instead of the TCRγ  peak, thereby 
suggesting a different origin between the 2 lymphoid neoplasms developed in the same subjects. 
This study indicated that GeneScan analysis would be a convenient and accurate method to 
determine the clonal origin of lymphoid neoplasms in dogs. 
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INTRODUCTION 
   Neoplasms are formed as a result of monoclonal proliferation originated from a single 
transformed cell. A normal ancestral cell acquires neoplastic phenotype through tumor 
progression, which causes accumulation of genetic or epigenetic alteration of genes associated 
with cell proliferation, survival, or other malignant characteristics. This process contributed to 
uncontrollable cell proliferation and eventually results in formation of primary neoplasms. This 
process is further responsible for progressive evolution of neoplasms toward greater degrees of 
aggressive and invasive behavior through a multi-step process.  
   Such process in canine hematopoietic malignancies has not been fully demonstrated so far. 
However, several reports have been published on lymphoid malignancies developing into more 
aggressive one in dogs. One case report described a dog with chronic lymphocytic leukemia 
(CLL) that subsequently progressed to acute lymphoblastic leukemia (ALL) (Takahashi et al., 
2007). Additionally, Comazzi et al. reported that three dogs secondarily developed high-grade 
lymphoma among 43 dogs that had been previously diagnosed with CLL (Comazzi et al., 2011).  
   Such clinical course in dogs is apparently similar to that in humans commonly referred to 
Richter’s syndrome (RS). In human medicine, 2 to 10% of cases of CLL and small lymphocytic 
lymphoma (SLL) developed diffuse large-cell lymphoma (DLL) over time 
(Maddocks-Christianson et al., 2007; Mauro et al., 1999; Rossi et al., 2008; Tsimberidou et al., 
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2006). Molecular mechanisms of RS such as the clonal relationship between the original and 
subsequent neoplasms has been intensively debated. Diverse studies have been conducted to 
characterize neoplasms for immunophenotype, immunoglobulin (Ig) gene rearrangement, Ig 
nucleotide sequence, or Ig isotype. It has been reported that in 67 (69%) of the 97 RS cases, two 
corresponding neoplasms in each individual were of the same clonal origin, and in remaining 30 
(31%), second neoplasm originated from unrelated clone (Smit et al., 2006). Thus, molecular 
analyses of RS suggest that development of secondary malignancies does not occur in a single 
homogenous manner in humans.  
   Studies on the clonal origin of 2 distinct lymphoid malignancies developed in the same 
individual can provide valuable information for management and understanding pathogenesis of 
lymphoid neoplasms; however, detailed analysis has not been conducted in veterinary medicine 
so far. Thus no information is available whether such course in dogs results from transformation 
of single clone or secondary diseases originated from independent clone. 
   Herein, I report a case series of 5 dogs with lymphoid malignancies subsequently developed 
into secondary lymphomas. The purpose of this study was to investigate the clonal relationship 
between original lymphoid malignancies and the subsequent lymphoma in dogs by means of 
PCR for antigen receptor gene rearrangements (PARR) and sequencing of complementary 
determining region 3 (CDR3). 
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MATERIALS AND METHODS 
Cases  
   Four dogs with lymphoma (marginal zone lymphoma [MZL], n = 2; T-zone lymphoma 
[TZL], n = 2), and 1 with B-cell chronic lymphocytic lymphoma (B-CLL) in the initial 
diagnosis were included in this study. The 2 dogs with MZL consisted of 1 dog with splenic 
MZL and 1 dog with nodal MZL. Progression to secondary lymphoma was confirmed in all 
dogs by re-examination at the time of recurrence of lymphadenopathy or clinical worsening 
more than 1 year after the initial diagnosis. All dogs had been referred to the Veterinary Medical 
Center of the University of Tokyo (VMC-UT) and medical records were reviewed for collecting 
patient’s information. The clinical data of the animals are summarized in Table 3-1. In all 
animals, DNA specimens of both primary and secondary lesions were available for analyses 
described below.  
 
Histopathology and Cytology 
   Splenic and/or lymph node tissues were surgically resected for the primary lesions in 4 cases 
(Case 1, 2, 4, 5) and 2 of the secondary lesions (Case 1, 4). The specimens were fixed in 10% 
formalin for 48 h, processed and paraffin embedded, cut into sections, and stained with 
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hematoxylin and eosin (HE). Immunohistochemistry was performed by streptavidin-biotin 
method using anti-CD3 antibody (polyclonal rabbit anti-human A0452; DAKO, Glostrup, 
Denmark; 1:50 dilution) for T-cell and anti-CD20 antibody (polyclonal rabbit anti-human 
RB-9013-P; Thermo Fisher Scientific, Waltham, MA; 1:400 dilution) for B-cell.  
   Bone marrow aspiration was performed in Case 3 for cytology of the primary lesions. 
Aspirate of enlarged lymph nodes were used to cytologically diagnose secondary lesions in 3 
dogs (Cases 2, 3, and 5). Cytological diagnoses were made from Wright−Giemsa-stained smear.  
   Histological or cytological diagnoses were reviewed from the archives. Diagnoses were 
made according to the World Health Organization (WHO) classification in the case with 
lymphoid malignancies (Valli et al., 2011). When the morphology of the cells in the FNA 
samples clearly indicated typical high-grade lymphoma (centroblastic type in updated Kiel 
classification (Fournel-Fleury et al., 1997)), resection biopsy of the lymph node was not 
performed. 
 
DNA Extraction 
   Genomic DNA was extracted from fresh specimens except for Cases 1, 2, and 5. Since fresh 
specimens were not available, paraffin-embedded tissues or smear preparation were used for 
DNA extraction in Cases 1, 2, and 5. DNA extraction was performed using a QIAamp DNA 
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Blood Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions, and 
subjected for PARR and sequencing.  
 
PCR for Antigen Receptor Gene Rearrangements 
   Rearrangements of the IgH/TCRγ genes for all specimens were assessed by GeneScan 
analytical system to determine lymphocyte clonality as described in the Materials and Methods 
section in Chapter 1.  
 
Cloning and Sequencing of CDR3 
   The specimens in which clonal rearrangements were detected in the same gene between 
primary and secondary lesions were subjected to sequencing of the CDR3. PCR products 
amplified by the method described above were cloned in the pGEM T-Easy Vector using the 
TA cloning system (Promega Corporation, Madison, WI) according to the manufacturer’s 
instructions. DNA Sequencing was performed from the plasmid preparation using a BigDye 
terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) and Applied 
Biosystems 3130xl genetic analyzer (Applied Biosystems). If diagnosis was made from several 
lesions, at least one of them was selected as sample for cloning and sequencing. 
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RESULTS 
Clinical Course 
   Case 1: A 4-year-old spayed female Pembroke Welsh Corgi was presented with enlargement 
of the right popliteal lymph node. Since regression was not observed by treatment with 
antibiotics, the lymph node was surgically resected for biopsy. Histopathological examination of 
the node indicated the characteristic appearance of MZL. There was no clinical sign or 
abnormality on examination, thus the dog was followed closely without treatment. On day 685, 
development of generalized lymphadenopathy was observed. On ultrasonography, 
splenomegaly and multiple hypoechoic nodules in spleen were detected. The right mandibular 
lymph node was surgically removed. Histopathological examination revealed follicular center 
cell lymphoma (FCCL) III in WHO classification. Treatment based on CHOP (prednisolone, 
doxorubicin, vincristine, and cyclophosphamide) protocol was given and complete remission 
(CR) was achieved. The dog was still alive without any clinical signs at the time the study was 
concluded (day 865). 
   Case 2: A 12-year-old spayed female Shi Zhu was presented with persistent lymphocytosis. 
On examination, total lymphocyte count of peripheral blood was 11,340/µL. Lymphocytes in 
peripheral blood were small and mature with aggregated chromatin. Enlargement of mandibular 
and popliteal lymph node was observed, while splenomegaly and multiple hypoechoic lesions 
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were detected in spleen by ultrasonography. Surgical resection of spleen and lymph nodes was 
performed, as well as bone marrow examination. The bone marrow was normoplastic, and the 
ratio of small lymphocytes in all nucleated blast cells was approximately 20%. MZL was 
histologically diagnosed. Although the dog was monitored without treatment, on day 58 
decreased activity and progression of lymphocytosis was observed. By treatment with 
melpharan, the dog eventually achieved CR, and the drug was withdrawn on day 177. On day 
412, lymphadenopathy relapsed, and high-grade B-cell lymphoma was diagnosed based on 
cytology of mandibular lymph node. Although treatment was given based on CHOP protocol, 
the dog died on day 569 of disease progression.   
   Case 3: A 7-year-old female Shiba was presented with persistent lymphocytosis. On 
examination, total white blood cell count was 235,400/µL (small lymphocytes, 230,600/µL). 
Hepatomegaly and splenomegaly were observed on ultrasonography. Since rapid clinical 
worsening was observed, bone marrow examination could not be performed. Therefore 
diagnostic therapy with chlorambucil and prednisolone was conducted, presumptively 
diagnosing CLL. Since CR was achieved, dosage was gradually tapered and completely 
withdrawn on day 273. On day 1,077, since increase of lymphocyte (14,100/µL) was observed 
again, bone marrow examination was performed. The bone marrow was hyperplastic, and the 
ratio of small lymphocytes in all nucleated blast cells was approximately 30%, and CLL was 
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definitively diagnosed. Although treatment with chlorambucil and prednisolone was reinstituted, 
generalized lymphadenopathy was subsequently found on day 1,239. Total lymphocytes count 
in peripheral blood was 46,100/µL, and enlargement of intraabdominal lymph nodes were 
detected on ultrasonography. High-grade B-cell lymphoma was diagnosed based on cytology of 
superficial lymph nodes. Treatment based on CHOP protocol was given and CR was achieved. 
The dog was still alive without any clinical signs at the time the study was concluded (day 
1,360). 
   Case 4; A 6-year-old castrated male Golden Retriever was presented with generalized 
lymphadenopathy. The right popliteal lymph node was surgically resected, and TZL was 
histologically diagnosed. There is no clinical sign or abnormality on examination, thus the dog 
was followed closely without treatment. On day 1,120, rapid progression of lymphadenopathy 
was observed. The left popliteal lymph node was surgically removed, and DLBCL was 
histologically diagnosed. The dog was given treatment based on CHOP protocol, and obtained 
partial remission (PR). Since lymphadenopathy relapsed on day 1,316, L-asparaginase and 
lomustine combination therapy was given as rescue regimen (Saba et al., 2007). However the 
dog died on day 1,381 from clinical worsening.   
   Case 5; A 8-year-old female Shi Zhu was presented with history of decreased activity and 
anorexia. On examination, generalized lymphadenopathy, anemia (PCV 27%), and 
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lymphocytosis (26,600/µl) were observed. Lymphocytes in the peripheral blood appeared as 
small and mature with aggregated chromatin in the nucleus. Surgical resection of the left 
superficial cervical lymph node was performed, as well as bone marrow aspiration. The bone 
marrow was normoplastic, and the ratio of small lymphocytes in all nucleated blast cells was 
11.1%. TZL was diagnosed based on histology of lymph node. Although the dog was given 
treatment with prednisolone and melpharan, lymphadenopathy recurred and anorexia was 
observed on day 1,125. High-grade B-cell lymphoma was cytologically diagnosed from LN 
aspirate. Although treatment based on CHOP protocol was given, disease progression was 
observed after remission for 91 days. There was no response to various rescue treatment 
(L-asparaginase, dacarbazine, cytosine arabinoside, and actinomycin D) and the dog died on day 
1,272. 
 
Assessment of Antigen Receptor Gene Rearrangements 
   The results of PARR analysis are shown in Table 3-2. Representative pattern of GeneScan 
analysis are shown in Fig. 3-1. All samples included in this study displayed monoclonal gene 
rearrangements in GeneScan analysis for antigen receptor gene rearrangements. Clonally 
rearranged genes were identical between primary and secondary lesions in 3 of the 5 dogs 
(Cases 1-3). Of these, all cases had identical size of PCR amplicons between two corresponding 
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lesions. In Cases 4 and 5, clonal rearrangements of TCRγ were detected in the primary lesion 
and IgH in the secondary lesion, indicating different clonal origin of the two corresponding 
lesions. 
 
Sequence of CDR3 
   Representative results of CDR3 sequence are shown in Fig. 3-2. All dogs (Cases 1-3) which 
showed identical size of PCR products between the primary and the secondary lesions also had 
identical CDR3 sequence, indicating the common clonal origin of the 2 corresponding lesions.  
 
DISCUSSION 
   In current study, I assessed the clonal relationship of the primary and the secondary lesions 
in 5 dogs with sequential development of morphologically distinct lymphoid malignancies. 
Three cases demonstrated identical CDR3 sequence between 2 corresponding lesions, indicating 
of the common clonal origin. Meanwhile, remaining 2 cases had clonal rearrangements in 
different genes between two corresponding lesions, indicating of the unrelated clonal origin. 
From these results, sequential development of 2 lymphoid malignancies in the same individual 
does not occur in homogenous pattern in dogs.   
   In human medicine, molecular mechanism involved in RS has been extensively studied; 
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however, there are many conflicting reports regarding clonal relationship between CLL/SLL 
and DLL in RS. A number of studies suggest that clonal evolution is underlying mechanism of 
RS (Cherepakhin et al., 1993; Cofrancesco et al., 1993; Traweek et al., 1993). Other studies 
suggest that the two neoplasms are originated from unrelated clone (Kerim et al., 1993; Sun et 
al., 1990; Tohda et al., 1990). These reports suggest that the lymphoma of RS patients had 
diverse clonal origin. Furthermore, patients with clonally related RS had a shorter survival time 
than patients with clonally unrelated RS in human (Rossi et al., 2011). Although the present 
study included only a small number of cases, heterogenous manner of sequential development 
of 2 different neoplasms was observed in dogs, being similar to human RS. Accumulation of 
data on clonal relationship may be important to reveal clinical significance as well as 
pathogenesis of the disease also in veterinary medicine. 
   Of the 5 dogs with sequential development of 2 lymphoid malignancies, 1 dog developed 
B-cell high-grade lymphoma from MZL. Frantz et al. reported that gene expression profile was 
very similar to each other between MZL and DLBCL in dogs by genomewide microarray 
analysis (Frantz et al., 2013). Thus, it was suggested that MZL and DLBCL is sequential 
diseases, and DLBCL may represent more advanced stage of the same disease. Although we did 
not perform histological evaluation on the secondary lesion of Case 2, our findings may be 
consistent with such clinical course. 
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   The results in this study indicate that lymphoma which is generally considered to have 
indolent course can transform into more aggressive type of lymphoma. While the incidence of 
malignant transformation in canine lymphoid malignancies has not been well understood, it has 
been reported that two B-cell high-grade lymphoma was developed among 17 B-CLL patients 
and one T-cell high-grade lymphoma among 19 T-CLL patients (Comazzi et al., 2011). 
Although it is generally considered that aggressive chemotherapy is not always necessary for 
indolent lymphoid malignancies, appropriate follow-up is essential for the cases with lymphoma 
even if it is recognized as indolent type. 
   In this study, 2 cases with TZL were found to develop secondary malignancies of different 
clonal origin. To our knowledge, there is only one case report describing development of two 
neoplasms originated from different clone in dog, which was developed high-grade B-cell 
lymphoma concurrent with T-CLL (Okawa et al., 2012). Occurrences of two lymphoid 
malignancies originated from unrelated clone have been defined also in humans by studies of 
immunophenotype or gene rearrangements, although its occurrence is less frequently than 
identical clone (Lee et al., 1995; Novogrudsky et al., 2001). Although the molecular mechanism 
of this phenomenon is unclear, immunosuppressive environment produced by primary 
neoplasms or chemotherapy are considered to be responsible for progression of secondary 
malignancies (Gottesman et al., 1999; Novogrudsky et al., 2001). Since alkylating agents play a 
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role in mutagenesis, it is possible to increase a risk of developing secondary leukemia in 
humans (Boffetta and Kaldor, 1994). In addition, persistent antigen stimulation can drive 
lymphocytes into uncontrollable clonal expansion. This chronic stimulation can result from the 
primary neoplasms itself (Wen et al., 1990) and lead reactive lymphocytes eventually to 
malignant transformation. The clinical course in dogs demonstrated in this study could result 
from a chance; however, underlying possible mechanisms of an increased risk for development 
of secondary lymphoma are remain to be further investigated in future studies. 
   In conclusion, I assessed the clonal relationship between primary and secondary lesions in 
dogs with 2 morphologically distinct types of lymphoid malignancies in the same individuals. I 
demonstrated 2 corresponding lesions had clonally identical origin in 3 cases. Therefore, 
appropriate follow-up is required even for indolent lymphoid malignancies, taking into account 
the potential of developing secondary malignancies with more aggressive nature. Further 
investigation is needed to clarify the clinical significance and underlying molecular mechanisms 
of malignant transformation in canine lymphoid malignancies. 
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Table 3-1  Diagnoses, and clinical information of the patients. 
 
a LN, lymph node; b BM, bone marrow; c L-Asp, L-asparaginase; d CHOP, prednisolone, doxorubicin, vincristine, and cyclophosphamide; e L-PAM, melpharan; f PDL, 
prednisolone; g CB, chlorambucil; h CR, complete remission. 
 
 
Case Breed Age Sex Site of Diagnosis Diagnosis Treatment 
Time to Development 
of the secondary lesion 
Follow-up 
(days) outcome 
1 Pembroke Welsh Corgi 4 Female 
(spayed)  
LN a Nodal marginal zone lymphoma  no treatment 685 865 CR h 
      LN  Follicular center cell lymphoma III L-Asp c, CHOP d       
2 Shi Zhu 12 Female 
(spayed) 
spleen Splenic marginal zone lymphoma L-PAM e, PDL f 448 569 Dead 
   
LN High-grade B-cell lymphoma L-Asp, CHOP 
   3 Shiba 7 Female BM b B-cell chronic lymphocytic leukemia CB g + PDL 1239 1365 CR 
        LN High-grade B-cell lymphoma L-Asp, CHOP       
4 Golden Retriever 6 Male 
(castrated) 
LN T-zone lymphoma no treatment 1131 1392 Dead 
      LN Diffuse large B-cell lymphoma CHOP       
5 Shi Zhu 8 Female LN T-zone lymphoma L-PAM + PDL 1125 1272 Dead 
    
LN High-grade B-cell lymphoma CHOP 
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             Table 3-2. The results of GeneScan analysis of the primary and the secondary lesions. 
 
 
 
 
 
 
 
              a IgH, immunoglobulin heavy chain gene; b TCRγ, T cell receptor gamma chain gene. 
Case Diagnosis Clonally rearranged gene  size of PCR products (bp) 
1 Nodal marginal zone lymphoma IgH a 86 
  Follicular center cell lymphoma IgH 86 
2 Splenic marginal zone lymphoma IgH 123 
 
High-grade B-cell lymphoma IgH 123 
3 B-cell chronic lymphocytic leukemia IgH 124 
  High-grade B-cell lymphoma IgH 124 
4 T-zone lymphoma TCRγ b 71 
  Diffuse large B-cell lymphoma IgH 118 
5 T-zone lymphoma TCRγ 74 
 
High-grade B-cell lymphoma IgH 112 
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Fig. 3-1. Results of GeneScan analysis for antigen receptor gene rearrangements of 
corresponding lesions in three cases. Samples used for the analysis were indicated at the bottom 
left corner of each plate. IgH, immunoglobulin heavy chain gene; MZL, marginal zone 
lymphoma; FCCL, follicular center cell lymphoma; High-G B, high-grade B-cell lymphoma; 
B-CLL, B-cell chronic lymphocytic lymphoma. 
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Fig. 3-2. Nucleotide sequence comparison of complementary determining region (CDR) 3 
between two corresponding lesions in three cases. The top and the bottom row in each case 
indicate sequence of the primary and the secondary lesions respectively. IgH, immunoglobulin 
heavy chain gene; MZL, marginal zone lymphoma; FCCL, follicular center cell lymphoma; 
High-G B, high-grade B-cell lymphoma; B-CLL, B-cell chronic lymphocytic lymphoma; F 
primer, forward primer; R primer, reverse primer. 
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CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 67 
   PARR has been widely accepted as a useful adjunctive method in the diagnostic procedures 
for lymphoid malignancies. Recently, GeneScan analysis has been introduced into human 
medicine alternatively to conventional PAGE method (van Dongen et al., 2003). GeneScan 
analysis has several advantages over the conventional method: high resolution, high-throughput, 
and ability to precisely identifying the length of nucleotide fragments. Thus, this novel assay 
has contributed to not only improvement of diagnostic accuracy but also to understanding of 
pathogenesis of lymphoid malignancies. Recently, studies using GeneScan analysis were also 
reported in veterinary medicine (Gentilini et al., 2009; Keller and Moore, 2012), and thus 
expected to provide new insights into canine lymphoproliferative diseases. Therefore, a series of 
studies in this thesis were conducted for the purpose of investigating the clinical utility and 
understanding of pathogenesis by applying GeneScan analysis to the clinical cases in dogs with 
lymphoproliferative diseases.  
   The study in Chapter 1 of the present thesis was carried out to investigate the relationship 
between PARR and histopathological diagnosis, and long-term prognosis in dogs, in order to 
evaluate the clinical significance of PARR in diagnosing GI lymphoma. Endoscopic biopsy 
specimens obtained from 96 dogs with chronic enteritis and 21 dogs with GI lymphoma were 
used. Clonal rearrangement in PARR was observed in 51% of the animals with chronic enteritis. 
While The sensitivity of PARR in animals with GI lymphoma was 76%. There was no 
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significant prognostic difference between chronic enteritis with or without clonal 
rearrangements. In contrast, dogs histopathologically diagnosed with marked enteritis had a 
significantly shorter survival time than did those with mild or moderate enteritis. While the 
significance of PARR in the diagnosis of GI lymphoma remains uncertain, the pathological 
roles of clonally expanding lymphocytes in canine CE should be investigated further. 
   Next in Chapter 2, the study was carried out to analyze the ability of GeneScan in detecting 
CTCs, and to investigate the prognostic significance depending on CTCs status in canine 
lymphoma. Samples from the primary lesions and PBMCs were obtained in 32 dogs with 
lymphoma at the initial diagnosis. As a result, in 13 of the 17 dogs (76%) with high-grade 
multicentric lymphoma, all of the 3 dogs with low-grade multicentric lymphoma, and 4 of the 
12 dogs (33%) with GI lymphoma, PARR results were positive and identical size of PCR 
products were detected between the primary lesions and PBMCs. Identical sequences of the 
PCR products were confirmed between the lesional sample and PBMCs, indicating the presence 
of CTCs. The GeneScan analysis employed in this study would facilitate the study on the 
clinical significance of CTCs in dogs with lymphoma. 
   In Chapter 3, I used GeneScan analysis to differentiate the clonal origin of cells in dogs that 
developed 2 different types of lymphoid malignancies. One dog with splenic MZL, a dog with 
B-CLL, and 2 dogs diagnosed with TZL developed secondary high-grade B-cell lymphoma 
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(DLBCL). One dog with an initial diagnosis of nodal MZL developed FCCL III more than 1 
year after the initial diagnosis. GeneScan analysis revealed a single peak of the IgH gene with 
the same length in both the primary (MZL and B-CLL) and secondary tumors in 3 dogs, 
indicating that the secondary tumors evolved from the pre-existing primary indolent neoplasm 
clone. A single TCRγ peak was identified in the 2 TZL samples. However, subsequent DLBCL 
samples from the same 2 dogs revealed a single peak of the IgH gene instead of the TCRγ  peak, 
thereby suggesting a different origin between the 2 lymphoid neoplasms developed in the same 
subjects. This study indicated that GeneScan analysis would be a convenient and accurate 
method to determine the clonal origin of lymphoid neoplasms in dogs. 
   The studies in this thesis suggest that clonal expansion of lymphocytes different from 
malignancy can occur both in lesions and peripheral blood. In previous study, it is reported that 
clonal proliferation can be detected in certain kinds of inflammatory diseases or infection both 
in human and veterinary medicine (Bakakos et al., 2001; Burnett et al., 2003), which was 
consistent with the present findings. Although PARR is a widespread additional tool for 
diagnosing lymphoid malignancies, the present study indicate that the results of PARR should 
be interpreted with sufficient caution particular from a single sample. Since the specificity of 
PARR in differentiating lymphoid malignancies from various inflammatory diseases is 
uncertain, this issue has to be investigated in the future studies.  
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   On the other hand, GeneScan analysis was demonstrated to be useful method in confirming 
the clonal relationship between multiple samples in the same individuals. Although final 
definition requires sequencing analysis, GeneScan can strongly suggest the presence of identical 
clone between the samples, which is more applicapable to clinical settings. As indicated in 
Chapter 2, this method might be valuable for predicting disease relapse and prognosis by 
monitoring CTCs, which would provide appropriate treatment for individual patients in the 
future. In addition, I demonstrated clonal relationship of 2 morphological distinct types of 
lymphoid neoplasms in dogs in Chapter 3.  
   In the present study, PARR analysis using GeneScan was applied to dog patients with 
lymphoproliferative disorders in various conditions, and association between each disease and 
growth of lymphoid cell clone was investigated. A series of these molecular biological studies 
revealed clinical utility of PARR analysis using GeneScan, and the relationship between the 
clonal cell expansion and development of lymphoproliferative diseases in dogs. I believe that 
translational research will be facilitated in veterinary clinical oncology by feeding back the 
outcome of these studies to the clinical practice. 
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